MetaADEDB 2.0 @ LMMD
Sarcoma
(UMLS:C1261473)
Definition:
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
UMLS ID:
C1261473
MeSH ID:
D012509
Classification:
Name:
Neoplasms
MeSH Tree Number(s):
C04.557.450.795
Synonym(s)
1.
Sarcoma
2.
Cancer of connective tissue
3.
Malignant connective tissue tumor
4.
Malignant mesenchymal tumor
5.
Malignant mesenchymal tumour
6.
Mesenchymal Tumor, Malignant
7.
Mesenchymal tumor, malignant
8.
Mesenchymal tumour, malignant
9.
SARCOMA
10.
SARCOMA, MALIGNANT
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1TeriparatideFAERS: 24US FAERS
2pazopanibFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
3Imatinib MesylateFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
4Fingolimod HydrochlorideFAERS: 8US FAERS
5LenalidomideFAERS: 7US FAERS
6SorafenibFAERS: 7US FAERS
7TacrolimusFAERS: 7US FAERS
8ClozapineFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
9IbuprofenFAERS: 6US FAERS
10ThalidomideFAERS: 6US FAERS
11Glatiramer AcetateFAERS: 5US FAERS
12NorgestrelFAERS: 5US FAERS
13AlprazolamFAERS: 3US FAERS
14AzacitidineFAERS: 32408741CTD
US FAERS
15CyclosporineFAERS: 3US FAERS
16DoxorubicinFAERS: 3

View details

CTD
US FAERS
17EverolimusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
18HydroxyureaFAERS: 3US FAERS
19SunitinibFAERS: 3US FAERS
20Zoledronic AcidFAERS: 3US FAERS
214-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 2US FAERS
22CarmustineFAERS: 2US FAERS
23Dimethyl FumarateFAERS: 2US FAERS
24DronedaroneFAERS: 2US FAERS
25EtoposideFAERS: 23114435
11254426
CTD
US FAERS
26GoserelinFAERS: 2US FAERS
27Ibandronic AcidFAERS: 2US FAERS
28LamotrigineFAERS: 2US FAERS
29Mycophenolic AcidFAERS: 2US FAERS
30PCI 32765FAERS: 2US FAERS
31SirolimusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
32ValsartanFAERS: 2US FAERS
33tofacitinibFAERS: 2US FAERS
34AlbuterolFAERS: 1US FAERS
35Aspirin, Dipyridamole Drug CombinationFAERS: 1US FAERS
36Aspirin-oxycodone hydrochloride-oxycodone terephthalate combinationFAERS: 1US FAERS
37AtorvastatinFAERS: 1US FAERS
38CanagliflozinFAERS: 1US FAERS
39CapsaicinFAERS: 1US FAERS
40CeftriaxoneFAERS: 1US FAERS
41CrizotinibFAERS: 1US FAERS
42DasatinibFAERS: 1US FAERS
43DeferasiroxFAERS: 1US FAERS
44DiclofenacFAERS: 1US FAERS
45DutasterideFAERS: 1US FAERS
46Estrogens, Conjugated (USP)FAERS: 1US FAERS
47FluticasoneFAERS: 1US FAERS
48GabapentinFAERS: 1US FAERS
49IfosfamideFAERS: 1

View details

CTD
SIDER
US FAERS
50Imatinib MesylateFAERS: 1US FAERS
51ImiquimodFAERS: 1US FAERS
52Insulin GlargineFAERS: 1US FAERS
53IsotretinoinFAERS: 1US FAERS
54MaloprimFAERS: 1US FAERS
55MethylprednisoloneFAERS: 1US FAERS
56OxycodoneFAERS: 1US FAERS
57PaclitaxelFAERS: 118074150
20406837
CTD
US FAERS
58PregabalinFAERS: 1US FAERS
59Raloxifene HydrochlorideFAERS: 1US FAERS
60Raltegravir PotassiumFAERS: 1US FAERS
61Risedronic AcidFAERS: 1US FAERS
62RisperidoneFAERS: 1US FAERS
63RivaroxabanFAERS: 1US FAERS
64Ruxolitinib phosphateFAERS: 1US FAERS
65Sitagliptin PhosphateFAERS: 1US FAERS
66Thallous chloride TL-201FAERS: 1US FAERS
67TrabectedinFAERS: 119238326CTD
US FAERS
68VareniclineFAERS: 1US FAERS
69apremilastFAERS: 1US FAERS
70exemestaneFAERS: 1US FAERS
71idelalisibFAERS: 1US FAERS
72macitentanFAERS: 1US FAERS
73osimertinibFAERS: 1US FAERS
74palbociclibFAERS: 1US FAERS
75pirfenidoneFAERS: 1US FAERS
76teriflunomideFAERS: 1US FAERS
77treprostinilFAERS: 1US FAERS
78venetoclaxFAERS: 1US FAERS
791,2,5,6-dibenzanthracene21863085CTD
801,2-Dimethylhydrazine9695784CTD
811,3-dichloro-1-propene292813CTD
821-sulfooxymethylpyrene24802129CTD
833-Hydroxyanthranilic Acid6248561CTD
843-methyl-2-naphthylamine6943385CTD
855-methylchrysene21863085CTD
867-monohydroxyethylrutoside17940501CTD
877H-dibenzo(c,g)carbazole21863085CTD
88AzathioprineCanada Vigilance: 1Canada Vigilance
SIDER
89Benzo(a)pyrene21863085
21942922
CTD
90CYVADIC protocol15304162CTD
91Caffeine10928167CTD
92Carboplatin1846407CTD
93Cyclophosphamide3047339
15205092
CTD
SIDER
94Dacarbazine

View details

CTD
95Dinoprostone2248514CTD
96Docetaxel7918126CTD
97Epirubicin16205946CTD
98EstradiolCanada Vigilance: 1Canada Vigilance
99Fluorouracil6603024CTD
100ICE protocol 110897015CTD
101Leucovorin6603024
6970616
CTD
102Lovastatin10815931
15943032
CTD
103MAID protocol12829150
16446334
CTD
104Medroxyprogesterone Acetate2947675CTD
105Mesna2858016
3102088
CTD
106Methotrexate3047339
6603024
6970616
CTD
107MethylphenidateCanada Vigilance: 1Canada Vigilance
108Polyvinyl Chloride12828392CTD
109Razoxane8636745CTD
110Streptozocin135666CTD
111TamoxifenSIDER
112VIA protocol15767644CTD
113Vindesine7438126CTD
114aniline21070798
21708182
CTD
115benz(a)anthracene21863085CTD
116benzo(b)fluoranthene21863085CTD
117benzo(k)fluoranthene21863085CTD
118bisphenol A19590677CTD
119chlorobromofosfamide11605069CTD
120dibenzo(a,e)pyrene21863085CTD
121dienogestCanada Vigilance: 1Canada Vigilance
122indeno(1,2,3-cd)pyrene21863085CTD
123turmeric extract18462866CTD
Similar ADE(s)
NameSemantic Similarity
1Angiomyolipoma45.7%
2Giant Cell Tumor of Bone37.6%
3Lipoma34.4%
4Myoma34.4%
5Myxoma34.4%
6Angiolipoma34.4%
7Myelolipoma34.4%
8Neoplasms, Bone Tissue34.4%
9Neoplasms, Fibrous Tissue34.4%
10Smooth Muscle Tumor34.4%
11Chondroma34.4%
12Enchondroma34.4%
13leukemia31%
14Neoplasms, Germ Cell and Embryonal31%
15Neoplasms, Glandular and Epithelial31%
16Germ Cell Cancer31%
17fibroma28.5%
18Fibromatosis28.5%
19Osteoblastoma28.5%
20Osteoma28.5%
21Rhabdomyoma28.5%
22Chondromatosis28.5%
23Adenofibroma26.7%
24Fibroadenoma26.7%
25Neuroectodermal Tumors26.7%
26Fibromatosis, Aggressive25.5%
27Fibromatosis, Abdominal25.5%
28Neoplasms, Neuroepithelial24.6%
29Gliomatosis cerebri24.6%
30Chondrosarcoma22.8%
31leiomyosarcoma22.8%
32liposarcoma22.8%
33synovial sarcoma22.8%
34Clear Cell Sarcoma of Soft Tissue22.8%
35Alveolar Soft Part Sarcoma22.8%
36melanoma22%
37Histiocytic Disorders, Malignant20.5%
38Adenoma20%
39Ameloblastoma20%
40Angiokeratoma20%
41Carcinoma20%
42Chordoma20%
43Hemangioma20%
44hemangiopericytoma20%
45Lymphangioma20%
46Mesenchymoma20%
47Nevus20%
48Teratoma20%
49Hepatoblastoma20%
50Mixed Tumor, Mullerian20%
51Germinoma20%
52Teratocarcinoma20%
53Angiofibroma20%
54Epithelioma20%
55Basal cell carcinoma19.6%
56Carcinoma, Papillary19.6%
57Squamous cell carcinoma19.6%
58Craniopharyngioma19.6%
59Cystadenoma19.6%
60Mesothelioma19.6%
61Neuroectodermal Tumor, Melanotic19.6%
62Neuroendocrine Tumors19.6%
63Carcinoma, Basal Cell19.6%
64Lymphangioleiomyomatosis19.5%
65Adenoma, Acidophil19.4%
66Ganglioneuroma19.4%
67Glioma19.4%
68Malignant Glioma19.4%
69Mastocytoma19.1%
70Medulloblastoma19.1%
71Fibrosarcoma18.9%
72Osteosarcoma18.9%
73Mastocytosis, Systemic18.9%
74Rhabdomyosarcoma18.8%
75Hamartoma18.5%
76Neoplasms, Hormone-Dependent18.5%
77Neoplasms, Multiple Primary18.5%
78Paraneoplastic Syndromes18.5%
79Precancerous Conditions18.5%
80Neoplasms, Second Primary18.5%
81Carcinoid Tumor18.1%
82Neurilemmoma18.1%
83Hutchinson's Melanotic Freckle18.1%
84Melanoma, Amelanotic18.1%
85Cystadenocarcinoma17.8%
86Mucoepidermoid Carcinoma17.8%
87Mastocytosis17.6%
88Meningioma17.4%
89Gastrointestinal Stromal Tumors17.4%
90Leukemia, Plasma Cell17.2%
91Malignant Fibrous Histiocytoma17%
92Dermatofibrosarcoma16.9%
93Dermatofibrosarcoma Protuberans16.9%
94Carcinoma, Ehrlich Tumor16.9%
95Dermoid Cyst16.9%
96Carcinoma, Lewis Lung16.9%
97Alveolar rhabdomyosarcoma16.8%
98Astrocytoma16.8%
99Ependymoma16.8%
100oligodendroglioma16.8%
101Ganglioglioma16.8%
102gliosarcoma16.8%
103Anaplastic astrocytoma16.8%
104Anaplastic Oligodendroglioma16.8%
105Malignant Carcinoid Syndrome16.2%
106Bowen's Disease16.1%
107Paraganglioma16.1%
108Composite Lymphoma15.8%
109Glioblastoma15.5%
110Neuroblastoma15.5%
111Glioblastoma Multiforme15.5%
112Melanoma, Experimental15.5%
113Lymphoma15.3%
114Trophoblastic Neoplasms15.3%
115Leukemia, Experimental15.1%
116Ganglioneuroblastoma14.9%
117Adenocarcinoma14.8%
118Carcinoma in Situ14.8%
119Carcinoma, Transitional Cell14.8%
120Dysgerminoma14.8%
121Hemangioendothelioma14.8%
122Neuroma14.8%
123Papilloma14.8%
124Pseudomyxoma Peritonei14.8%
125Seminoma14.8%
126Papillomatosis14.8%
127Adenomatosis, Pulmonary14.8%
128Adenomatous Polyps14.8%
129Carcinoma, Large Cell14.8%
130Carcinoma, Small Cell14.8%
131Pheochromocytoma14.4%
132Leukemia L121014.3%
133Leukemia P38814.3%
134Acanthoma14.3%
135Choriocarcinoma13.4%
136Carcinoma, Lobular13.4%
137Plasmacytoma13.3%
138Carcinosarcoma13.2%
139Hemangiosarcoma13.2%
140Malignant histiocytosis13.2%
141lymphangiosarcoma13.2%
142Histiocytic sarcoma13.2%
143Dupuytren Contracture13.2%
144Urticaria Pigmentosa12.8%
145Carcinoid Heart Disease12.4%
146Carcinoma 256, Walker12.4%
147Thymoma12.4%
148Neurofibrosarcoma12.4%
149Leukemia, Radiation-Induced12.2%
150Adenoid Cystic Carcinoma12.2%
151Cyst12.2%
152Neoplastic Processes12.2%
153Neoplastic Syndromes, Hereditary12.2%
154Pregnancy Complications, Neoplastic12.2%
155Adenocarcinoma, Clear Cell12.2%
156Cholangiocarcinoma12.2%
157Cervical Intraepithelial Neoplasia12.2%
158Hemangioblastoma12.2%
159Lymphoma, Extranodal NK-T-Cell12.2%
160Neoplasms, Experimental11.9%
161Retinoblastoma11.1%
162Klatskin Tumor10.9%
163Abdominal Neoplasms10.3%
164Erythroplasia10.3%
165Follicular cyst10.3%
166Head and Neck Neoplasms10.3%
167Mucocele10.3%
168Pilonidal Cyst10.3%
169Soft Tissue Neoplasms10.3%
170Thoracic Neoplasms10.3%
171Thyroglossal Cyst10.3%
172Synovial Cyst10.3%
173Aberrant Crypt Foci10.3%
174Hodgkin Disease9.8%
175Lymphoma, Non-Hodgkin9.8%
176Leukemia, Myelomonocytic, Chronic9.8%
177Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative9.8%
178Sarcoma, Myeloid9.8%
179Multiple Endocrine Neoplasia9.2%
180Neoplasms, Radiation-Induced8.8%
181Lymphomatoid Granulomatosis8.8%
182Paraneoplastic Encephalomyelitis8.6%
183Hydatidiform Mole8.5%
184Mammary Neoplasms, Experimental8.4%
185Acoustic Neuroma8.4%
186Carcinoma, Pancreatic Ductal8.3%
187Leukemia, Myeloid, Chronic-Phase8.1%
188Primary amyloidosis7.9%
189Hepatocellular Adenoma7.9%
190Endometrial Stromal Sarcoma7.7%
191Basal Cell Nevus Syndrome7.7%
192Sturge-Weber Syndrome7.6%
193Optic Nerve Glioma7.5%
194Nephroblastoma7.5%
195Vipoma7.4%
196Hemangioma, Cavernous7.4%
197Digestive System Neoplasms7.3%
198Endocrine Gland Neoplasms7.3%
199Eye Neoplasms7.3%
200Leukemia, T-Cell7.3%
201Nervous System Neoplasms7.3%
202Leukemia, B-Cell7.3%
203neurofibroma7.3%
204Lymphoma, Follicular7.3%
205T-Cell Lymphoma7.3%
206Mantle cell lymphoma7.3%
207Bone neoplasms7%
208Leukoplakia7%
209Lymphocele7%
210Pancreatic Cyst7%
211Skin Neoplasms7%
212Hematologic Neoplasms7%
213Barrett Esophagus6.8%
214Breast Cyst6.8%
215Actinic keratosis6.8%
216Mediastinal Cyst6.8%
217Neoplasm Invasiveness6.8%
218Neoplasm Metastasis6.8%
219Neoplasm Recurrence, Local6.8%
220Parovarian Cyst6.8%
221Pericardial Cyst6.8%
222Splenic Neoplasms6.8%
223Thymic Cyst6.8%
224Carcinogenesis6.8%
225Myxoid cyst6.8%
226Metastasis6.8%
227Mesoblastic Nephroma6.7%
228Retroperitoneal Neoplasms6.7%
229Prolactinoma6.5%
230Growth Hormone-Secreting Pituitary Adenoma6.5%
231Tuberous Sclerosis6.1%
232Multiple Endocrine Neoplasia Type 16%
233Precursor B-Cell Lymphoblastic Leukemia-Lymphoma6%
234Leukemia, Large Granular Lymphocytic6%
235Precursor T-Cell Lymphoblastic Leukemia-Lymphoma6%
236Lymphoma, T-Cell, Cutaneous6%
237Lymphoma, AIDS-Related6%
238Enteropathy-Associated T-Cell Lymphoma6%
239Primary Effusion Lymphoma6%
240insulinoma5.7%
241Waldenstrom Macroglobulinemia5.7%
242Multiple Myeloma5.7%
243granulosa cell tumor5.5%
244Carcinoma, Ovarian Epithelial5.5%
245Parathyroid Neoplasms5.5%
246Peritoneal Neoplasms5.5%
247Thyroid Neoplasm5.5%
248Thyroid carcinoma5.5%
249Gastrinoma5.4%
250Glucagonoma5.4%
251Mycosis Fungoides5.4%
252Lymphomatoid Papulosis5.4%
253Plasmablastic lymphoma5.4%
254Adrenocortical carcinoma5.4%
255Adenomatous Polyposis Coli5.1%
256Corpus Luteum Cyst5%
257Ovarian Cysts5%
258Liver Neoplasms, Experimental5%
259Sarcoma, Experimental5%
260Leydig Cell Tumor4.9%
261Tracheal Neoplasms4.8%
262Leukoplakia, Oral4.6%
263Paraneoplastic Cerebellar Degeneration4.6%
264Pancreatic Neoplasm4.6%
265Renal Cell Carcinoma4.6%
266Papillary Renal Cell Carcinoma4.6%
267Mouth Neoplasms4.5%
268Central Nervous System Neoplasms4.5%
269Vascular Neoplasms4.5%
270Thymus Neoplasms4.5%
271Nasopharyngeal carcinoma4.5%
272Carcinoma, Endometrioid4.4%
273Genital Neoplasms, Female4.4%
274Pancreatic Pseudocyst4.4%
275Lymphatic Metastasis4.4%
276Neoplasms, Unknown Primary4.4%
277Leukemic Infiltration4.4%
278Breast Neoplasms, Male4.4%
279Neoplasm Micrometastasis4.4%
280Triple Negative Breast Neoplasms4.4%
281Sarcoma 1804.4%
282Choledochal Cyst4.1%
283Burkitt Lymphoma4%
284Peutz-Jeghers Syndrome4%
285Thyroid Nodule3.9%
286Esophageal Neoplasms3.9%
287Limbic Encephalitis3.8%
288Denys-Drash Syndrome3.8%
289Sezary Syndrome3.6%
290Adrenal Gland Neoplasms3.4%
291Gastrointestinal Neoplasms3.4%
292Genital Neoplasms, Male3.4%
293Liver neoplasms3.4%
294Uveal Neoplasms3.4%
295Urologic Neoplasms3.4%
296Lambert-Eaton Myasthenic Syndrome3.3%
297Testicular Neoplasms3.3%
298Sebaceous Gland Neoplasms3.3%
299Spinal Neoplasms3.3%
300Bone Marrow Neoplasms3.3%
301Meningeal Neoplasms3.3%
302Polycystic Ovary Syndrome3.3%
303Opsoclonus-Myoclonus Syndrome2.9%
304Meningeal Carcinomatosis2.7%
305Palatal Neoplasms2.6%
306Ear Neoplasms2.6%
307Eyelid Neoplasms2.6%
308Lung Neoplasms2.6%
309Pleural Neoplasms2.6%
310Myelitis, Transverse2.6%
311Nose Neoplasms2.6%
312Cell Transformation, Viral2.5%
313Brain Neoplasms2.5%
314Salivary Gland Neoplasms2.5%
315Spinal Cord Neoplasms2.5%
316Tongue Neoplasms2.5%
317Uterine Neoplasms2.4%
318Vaginal Neoplasms2.4%
319Vulvar Neoplasms2.4%
320Uterine Cancer2.4%
321Fallopian Tube Neoplasms2.4%
322Xeroderma Pigmentosum2.2%
323Pituitary Adenoma2.2%
324Pituitary Neoplasms2.2%
325ovarian neoplasm2.2%
326Bronchial Neoplasms2.1%
327Pharyngeal Neoplasms2.1%
328Multiple Pulmonary Nodules2.1%
329Supratentorial Neoplasms2%
330Central Nervous System Cysts2%
331Endometrial Neoplasms2%
332Bile Duct Neoplasms2%
333gallbladder neoplasm2%
334Intestinal Neoplasms2%
335Penile Neoplasms2%
336Prostatic Neoplasms2%
337Stomach Neoplasms2%
338Polycythemia Vera1.9%
339Brain Stem Neoplasms1.8%
340Laryngeal neoplasm1.7%
341Choroid Plexus Papilloma1.7%
342Hypopharyngeal Neoplasms1.7%
343Pleural Effusion, Malignant1.7%
344Hypopharyngeal Cancer1.7%
345Zollinger-Ellison syndrome1.6%
346Bladder Neoplasm1.6%
347Kidney Neoplasm1.6%
348Ureteral Neoplasms1.6%
349Urethral Neoplasms1.6%
350Parotid Neoplasms1.6%
351Prostatic Neoplasms, Castration-Resistant1.6%
352Nelson Syndrome1.6%
353Tonsillar Neoplasms1.5%
354Cerebellar Neoplasms1.4%
355Cecal Neoplasms1.3%
356Duodenal Neoplasms1.3%
357Radicular Cyst1.2%
358Appendiceal Neoplasms1.2%
359Colonic Neoplasms1.2%
360Rectal Neoplasms1.2%
361Nasopharyngeal Neoplasms1.2%
362Colorectal Neoplasms1.2%
363Paranasal Sinus Neoplasms1%
364Anus Neoplasms1%
365Sigmoid Neoplasms1%
366Maxillary Sinus Neoplasms0.9%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.